The Library
Long-term survival after treatment for Hodgkin's disease (1973-2002) : improved survival with successive 10-year cohorts.
Tools
Tools
Tools
Bessell, E. M., Bouliotis, Georgios, Armstrong, S, Baddeley, J., Haynes, A. P., O'Connor, S., Nicholls-Elliott, H. and Bradley, M. (2012) Long-term survival after treatment for Hodgkin's disease (1973-2002) : improved survival with successive 10-year cohorts. British Journal of Cancer, 107 (3). pp. 531-536. ISSN 0007-0920.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Abstract
Background:
The Nottinghamshire Lymphoma Registry contains the details of all the patients diagnosed with lymphoma (since 1 January 1973) within a defined geographical area with a population of 1.1 million. It was therefore possible to study the outcome of treatment for Hodgkin’s disease for three 10-year cohorts (1973–1982, 1983–1992 and 1993–2002).
The aims of the study were to compare survival time among the three patient cohorts, to identify prognostic factors and to estimate relative survival.
Methods:
A total of 745 patients diagnosed between 1973 and 2002 were analysed for survival. Survivorship was estimated by the Kaplan-Meier method and parametric survival models. An accelerated failure-time regression was used for multivariate analysis.
Results:
Overall, patients were observed for 9.8 (0.3–34.82) years (median(range)), on average. One, five and fifteen-year disease-specific survival was found to be 87% (85–90%), 77% (74–80%) and 70% (67–74%), respectively. For those for diagnosed between 1973 and 1982, the 15-year survival was found to be 57%; for 1983–1992, it was 74% and for 1993–2002, it was 83% (P<0.001). The difference remained significant after adjusting for prognostic factors. The actuarial risk of developing a second malignancy at 20 years was for the 1973–1982 cohort, 12.4%, and for the 1983–1992 cohort, 18.8%.
Conclusion:
Treatment advances and effective management of toxicities of treatment over time, have resulted in a significantly longer survival for patients with Hodgkin’s disease diagnosed within a defined population.
| Item Type: | Journal Article | ||||||
|---|---|---|---|---|---|---|---|
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||||
| Journal or Publication Title: | British Journal of Cancer | ||||||
| Publisher: | Nature Publishing Group | ||||||
| ISSN: | 0007-0920 | ||||||
| Official Date: | 24 July 2012 | ||||||
| Dates: |
|
||||||
| Volume: | 107 | ||||||
| Number: | 3 | ||||||
| Page Range: | pp. 531-536 | ||||||
| Status: | Peer Reviewed | ||||||
| Publication Status: | Published | ||||||
| Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
